Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Assessment of the Risk of Peripartum Hemorrhage in Pregnant Women : Retrospective Assessment of the Diagnostic Performance of the HEMSTOP Standardized Questionnaire

NCT05191251 is registered in ClinicalTrials.gov with Brugmann University Hospital as lead sponsor.

NCT NCT05191251
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05191251 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Assessment of the Risk of Peripartum Hemorrhage in Pregnant Women : Retrospective Assessment of the Diagnostic Performance of the HEMSTOP Standardized Questionnaire
Lead sponsor
Brugmann University Hospital
Phase
Observational
Overall status
Completed
Start date
January 13, 2022
Completion date
June 30, 2022
Enrollment
3,588 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemorrhage, hemstop questionnaire, peripartum period